Actinium Pharmaceuticals Inc. (Delaware) (ATNM) declined -5.07% or -0.03 to $0.59. It is near to 208333 shares traded, which is 22.23% compare to the average total volume 937188. The market cap of ATNM is $68.10 million. The year to date change is 37.04%. The 52 week price range is from $0.33 to $0.87. Price of ATNM have changed 2.77% during last week. It have changed 11.69% over last month, 31.91% over last 3 months, -6.06% over last 6 months and 39.33% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ATNM is 0.51. It is -13.56% below current price. The 200-day Moving Averages for ATNM is 0.58. It is -1.69% below current price. The 52-week High is 0.87. It is 47.46% from the current price. The 52-week Low is 0.33. It is -44.07% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of ATNM is 3.81 on 2019-02-15. Short % to float is 1.90%. There are some statistics of ATNM. It is has market cap $68.10 million. The share outstanding is 115.70 million. The average volume is 937188. The percent of top 15 Institution holding is 13.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ATNM is -151.13%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ATNM is -120.23%.